Long-term efficacy, including halting of radiographicprogression, and safety of etanercept in patients with ankylosing spondylitis

被引：0
|
作者：
Dijkmans, B.
Sridharan, S.
Fatenejad, S.
机构：
[1] Vrije Univ Amsterdam, Dept Rheumatol, Amsterdam, Netherlands
[2] Wyeth Ayerst Res, Res & Dev, Collegeville, MN USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：187 / 187
页数：1
相关论文
共 50 条
  • [21] Sustained efficacy and safety of patients with ankylosing spondylitis treated with etanercept: Outcomes at 148-160 weeks of long term therapy.
    Sieper, Joachim
    Dijkmans, Benjamin A. C.
    van der Linden, Sjef
    Mola, Emilio Martin
    Sibilia, Jean
    Leirisalo-Repo, Majatta
    Nab, Henk W.
    Chang, David
    Freundlich, Bruce
    MacPeek, David
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S473 - S473
  • [22] Five-year efficacy and safety, including patient-reported outcomes, with etanercept in ankylosing spondylitis
    Mola, E. Martin
    van der Linden, S.
    Wishneski, C.
    Robertson, D.
    Freundlich, B. F.
    Koenig, A. S.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S584 - S585
  • [23] Radiographic results from a long-term multicenter trial of etanercept ENBREL®) in patients with Ankylosing Spondylitis.
    Dijkmans, B
    Wanders, A
    van der Heijde, D
    Fatenejad, S
    Afdeling, R
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S634 - S634
  • [24] Long-term safety and efficacy of etanercept in the treatment of psoriasis
    Zaragoza, V.
    Perez, A.
    Sanchez, J. L.
    Oliver, V.
    Martinez, L.
    Alegre, V.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (01): : 47 - 53
  • [25] Adalimumab reduces pain, fatigue, and stiffness in patients with ankylosing spondylitis: Results from the Adalimumab Trial Evaluating Long-Term Safety and Efficacy for Ankylosing Spondylitis (ATLAS)
    Revicki, Dennis A.
    Luo, Michelle P.
    Wordsworth, Paul
    Wong, Robert L.
    Chen, Naijun
    Davis, John C., Jr.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (07) : 1346 - 1353
  • [26] Sustained efficacy and safety, including patient-reported outcomes, with etanercept treatment over 5 years in patients with ankylosing spondylitis
    Martin-Mola, E.
    Sieper, J.
    Leirisalo-Repo, M.
    Dijkmans, B. A. C.
    Vlahos, B.
    Pedersen, R.
    Koenig, A. S.
    Freundlich, B.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : 238 - 245
  • [27] LONG-TERM EFFECTS OF ETANERCEPT TREATMENT ON VASCULAR FUNCTION AND LIPID PARAMETERS IN ANKYLOSING SPONDYLITIS
    Bodnar, N.
    Kerekes, G.
    Vegh, E.
    Gulyas, K.
    Balazs, F.
    Pogacsas, L.
    Pal, I.
    Szekanecz, Z.
    Szanto, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 958 - 958
  • [28] Observation of Clinical Efficacy of Etanercept and Infliximab in Patients with Ankylosing Spondylitis
    Zhang, Fengfei
    Sun, Qingzeng
    Qi, Yudong
    Shen, Yang
    Shi, Yingchun
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2020, 126 : 426 - 427
  • [29] Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice
    Arends, S.
    Brouwer, E.
    Efde, M.
    van der Veer, E.
    Bootsma, H.
    Wink, F.
    Spoorenberg, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : 61 - 68
  • [30] Long-term safety of etanercept
    Langley, Richard G.
    Keystone, Edward C.
    Bissonnette, Robert
    Papp, Kim A.
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2007, 11 : S23 - S36
12345